Genmab — Marts 2021
-
-
Italians a bit slow... The Italian Medicines Agency (AIFA) has approved the reimbursement of Darzalex (daratumumab) when used in combination with lenalidomide and dexamethasone or bortezomib, melphalan and prednisone for patients with multiple myeloma. https://www.eversana.com/2021/03/01/last-week-in-review-2-22-2021-2-26-2021/
-
I
-
I'll bet Alex Gorsky already is running an alias at PI
-
-
Desværre ikke Bulder.
-
Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies https://journals.lww.com/hemasphere/Fulltext/2021/01000/Potent_Preclinical_Efficacy_of_DuoHexaBody_CD37_in.3.aspx
-
'the combination of DuoHexaBody-CD37 with ofatumumab significantly enhanced the tumor cell kill in an additive manner' as a reminder , from earningscall 'one of the obvious candidates, of course, is potentially epco to basically combine it with the CD37 type of antibody. Because CD37 and CD20 are co-expressed for many targets'
-
i can't read the article, but prostate cancer is a big market.... 'CD38 as a Novel Immunosuppressive Target in Prostate Cancer' https://www.sciencedirect.com/science/article/abs/pii/S0302283821001421?via%3Dihub
-
Ja man bliver ved med at lege med tanken om dara og solid cancer https://www.hindawi.com/journals/jo/2021/6630295/
-
Har i hørt vittigheden om den dag, hvor US åbnede og GEN ikke faldt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind